Contents
Issue 132 • July 2023
In association with
In Depth
AI for patients: Hype or Hope
Readmission on the Horizon: How EU funding can boost British biotech
NASH drugs race to cross the finish line
Can vouchers incentivise antimicrobial drug discovery in Europe?
Q&A: How Big Pharma implements analytics in continuous manufacturing
Inflation reduction act boosts biologic VC financing over small molecules
